Turkey. The Market Authorization Holder for celecoxib (Celebrex) in Turkey has voluntarily withdrawn celebrex from the Turkish market. The Turkish Human Medicinal Products Advisory Committee had earlier directed that the labels of celecoxib (Celebrex 100 mg and 200 mg) capsules should state that the product may not be used by individuals who have obstructive arterial disorder of the cardiovascular system or the central nervous system.

Reference:

Press Release from the Turkish Ministry of Health and Communication from the Turkish Clinical Pharmacological Society, November 2004.